ANDA 216096, held by Dexcel. Omeprazole Magnesium.
As of Nov 16, 2026, ANDA 216096 (Omeprazole Magnesium), held by Dexcel, was first approved by FDA on May 24, 2022, with 2 approved supplements and 0 published complete response letters.
Use
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 24, 2022 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Omeprazole MagnesiumEQ 20MG BASE · capsule, delayed release;oral | Omeprazole Magnesium | OTC |
| Jun 5, 2025 | Supplement 5Manufacturing | Approved | None posted |
| Jul 20, 2023 | Supplement 2Labeling · Standard review | Approved | None posted |
| May 24, 2022 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters